Piper Sandler Upgrades Travere Therapeutics (TVTX) to Overweight

April 14, 2026 11:10 AM

Piper Sandler analyst Allison M. Bratzel upgraded Travere Therapeutics (NASDAQ: TVTX) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found